News
License out/inDrug Approval
6 hours ago
Cell TherapyImmunotherapyClinical Result
21 Nov 2026
Cell Therapy
21 Nov 2026
License out/inImmunotherapyCell Therapy
21 Nov 2026
AcquisitionLicense out/inADC
21 Nov 2026
Scribe Therapeutics Presents New Data Advancing the Potential of Ultra-Long-Acting Genetic Medicines for Cardiovascular Disease at AHA Scientific Sessions 2026
Clinical ResultGene TherapyAHA
21 Nov 2026
HUTCHMED Announces China NMPA Approval of SYVIK® (sovleplenib) for the Treatment of Primary Immune Thrombocytopenia and Warm Antibody Autoimmune Hemolytic Anemia
Clinical ResultImmunotherapyDrug ApprovalOrphan Drug
21 Nov 2026
Gastric cancer filing for AstraZeneca's Claudin 18.2-targeting ADC gets speedy FDA review
ADCClinical ResultPriority ReviewDrug Approval
21 Nov 2026
Recursion Announces Alignment with FDA on Registrational Phase 3 Trial Design for REC-4881 in Familial Adenomatous Polyposis
Clinical ResultFast TrackOrphan Drug